These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32274109)
21. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease. Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182 [TBL] [Abstract][Full Text] [Related]
22. [New markers of cardio-renal links in chronic kidney disease]. Milovanova LIu; Milovanov IuS; Kozlovskaia LV; Mukhin NA Ter Arkh; 2013; 85(6):17-24. PubMed ID: 23866594 [TBL] [Abstract][Full Text] [Related]
23. Association of serum phosphate with vascular and valvular calcification in moderate CKD. Adeney KL; Siscovick DS; Ix JH; Seliger SL; Shlipak MG; Jenny NS; Kestenbaum BR J Am Soc Nephrol; 2009 Feb; 20(2):381-7. PubMed ID: 19073826 [TBL] [Abstract][Full Text] [Related]
24. Phosphate and Klotho. Kuro-O M Kidney Int; 2011 Apr; 79121():S20-3. PubMed ID: 26746857 [TBL] [Abstract][Full Text] [Related]
25. Coronary artery calcification and cardiovascular disease in children with chronic kidney disease. Paoli S; Mitsnefes MM Curr Opin Pediatr; 2014 Apr; 26(2):193-7. PubMed ID: 24632542 [TBL] [Abstract][Full Text] [Related]
26. Soluble α -Klotho Serum Levels in Chronic Kidney Disease. Rotondi S; Pasquali M; Tartaglione L; Muci ML; Mandanici G; Leonangeli C; Sales S; Farcomeni A; Mazzaferro S Int J Endocrinol; 2015; 2015():872193. PubMed ID: 25873958 [TBL] [Abstract][Full Text] [Related]
27. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA; Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743 [TBL] [Abstract][Full Text] [Related]
28. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026 [TBL] [Abstract][Full Text] [Related]
29. Vascular calcification in chronic kidney disease. Jono S; Shioi A; Ikari Y; Nishizawa Y J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129 [TBL] [Abstract][Full Text] [Related]
30. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
31. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Sawires HK; Essam RM; Morgan MF; Mahmoud RA Nephron; 2015; 129(4):293-9. PubMed ID: 25766835 [TBL] [Abstract][Full Text] [Related]
32. Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation. Disthabanchong S; Vipattawat K; Phakdeekitcharoen B; Kitiyakara C; Sumethkul V Int Urol Nephrol; 2018 Feb; 50(2):355-364. PubMed ID: 29236239 [TBL] [Abstract][Full Text] [Related]
33. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification. Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521 [TBL] [Abstract][Full Text] [Related]
34. Circulating α-klotho levels in CKD and relationship to progression. Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260 [TBL] [Abstract][Full Text] [Related]
35. Phosphate and Klotho. Kuro-O M Kidney Int Suppl; 2011 Apr; 79(121):S20-3. PubMed ID: 21346722 [TBL] [Abstract][Full Text] [Related]
36. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho. Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455 [TBL] [Abstract][Full Text] [Related]
37. Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease. Chen J; Zhang X; Zhang H; Liu T; Zhang H; Teng J; Ji J; Ding X Int J Biol Sci; 2016; 12(10):1236-1246. PubMed ID: 27766038 [TBL] [Abstract][Full Text] [Related]
38. Serum sclerostin as a potential novel biomarker for heart valve calcification in patients with chronic kidney disease. Ji YQ; Guan LN; Yu SX; Yin PY; Shen XQ; Sun ZW; Liu J; Lv W; Yu GP; Ren C Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8822-8829. PubMed ID: 30575924 [TBL] [Abstract][Full Text] [Related]
39. [EVALUATION OF CARDIOVASCULAR RISKS WITH THE USE OF MORPHOGENETIC KLOTHO PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASE]. Mukhin NA; Milovanova LY; Fomin VV; Kozlovskaya LV; Taranova MV; Androsova TV; Borisov AA Klin Med (Mosk); 2017; 95(3):272-7. PubMed ID: 30303650 [TBL] [Abstract][Full Text] [Related]
40. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]. Omata M; Fukagawa M; Kakuta T Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]